Skip to content
GLP-1 Scorecard
Menu
Site position #361

Form Health

Published by GLP-1 ScorecardUpdated

Brand-name only telehealth provider offering Wegovy, Ozempic, and Mounjaro at standard pharmacy pricing with physician oversight.

Visit Form HealthWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$1,350/mo (starting dose, brand-name)
Tirzepatide
$1,350/mo (starting dose, brand-name)
Coverage
All 50 states
Brand-name
Yes

Weigh Form Health against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value29/100
Dose & formulation77/100
Clinical oversight86/100
Labs & monitoring52/100
Fulfillment81/100
Contract terms41/100

Strengths

  • Both semaglutide and tirzepatide available
  • Brand-name FDA-approved medications

What to consider

  • Higher brand-name pricing only
  • Premium pricing relative to market

Bottom line — Grade C

Best for: Shoppers who want comprehensive concierge care.

Site position #361 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest Form Health — the realistic shortlist.

The 20 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Form Health's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Form Health's site. Not medical advice; see our disclosure.

← Back to the scorecard